AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1897688 — intervention group
Group type: EXPERIMENTAL
Intervention: L-648,051 (800 micrograms) inhaled before the expected late reaction (2.5 h after antigen challenge)
Number of subjects: 12
Study 7212014 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenses fitted 1 D flatter than 'K'
Number of subjects: 29
Study 7212014 — intervention group
Group type: COMPARATOR
Intervention: Other treatment groups (not specified)
Number of subjects: 29
Study 30859940 — intervention group
Group type: EXPERIMENTAL
Intervention: SPN-812 (100-400mg for children, 200-600mg for adolescents)
Number of subjects: 1200
Study 30859940 — intervention group
Group type: EXPERIMENTAL
Intervention: SPN-812
Number of subjects: 1200
Study 30859940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study 28542611 — intervention group
Group type: EXPERIMENTAL
Intervention: ZIKV testing (plasma samples for ZIKV nucleic acid and antibodies)
Number of subjects: 1001
Study 28542611 — intervention group
Group type: EXPERIMENTAL
Intervention: Euroimmun anti-Zika ELISA testing
Number of subjects: 1001
Study 26616225 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib (80mg p.o. b.i.d.) combined with PLD (30mg/m2, IV) and carboplatin (AUC 5, IV)
Number of subjects: 39
Study 26616225 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib (80mg p.o. b.i.d.) combined with PLD and carboplatin plus bevacizumab (10mg/kg on days 1 and 15)
Number of subjects: 39
Study 24825530 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 40 mg (D40)
Number of subjects: 101
Study 24825530 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg (D8)
Number of subjects: 101
Study 24825530 — intervention group
Group type: COMPARATOR
Intervention: Placebo (D0)
Number of subjects: 101
Study 22486858 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin in addition to peginterferon alfa‐2a and ribavirin
Number of subjects: 98
Study 20390477 — intervention group
Group type: EXPERIMENTAL
Intervention: VCT-ID
Number of subjects: 301
Study 20390477 — intervention group
Group type: COMPARATOR
Intervention: ID
Number of subjects: 301
Study 17440005 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation of ICD therapies for atrial tachyarrhythmia (AT)/atrial fibrillation (AF)
Number of subjects: 122
Study 17440005 — intervention group
Group type: COMPARATOR
Intervention: Control group (deactivation of ICD therapies for AT/AF)
Number of subjects: 122
Study 15738747 — intervention group
Group type: EXPERIMENTAL
Intervention: donepezil (5 mg, twice a day)
Number of subjects: 26
Study 15738747 — intervention group
Group type: COMPARATOR
Intervention: placebo (twice a day)
Number of subjects: 26
Study 11952104 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary stenting
Number of subjects: 101
Study 9472754 — intervention group
Group type: EXPERIMENTAL
Intervention: 8‐day course of 40 mg/day prednisone
Number of subjects: 15
Study 9472754 — intervention group
Group type: COMPARATOR
Intervention: 8‐day tapering course of prednisone (tapering from 40 mg to 0 mg)
Number of subjects: 15
Study 8598422 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (90 mg/day for 3 weeks)
Number of subjects: 10
Study 8598422 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 10
Study 2686454 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri‐Levlen
Number of subjects: 206
Study 2686454 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho‐Novum 7/7/7
Number of subjects: 206
Study 2686454 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri‐Norinyl
Number of subjects: 206
Study 2686454 — intervention group
Group type: COMPARATOR
Intervention: Nonhormonal forms of birth control
Number of subjects: 206
Study 30256552 — intervention group
Group type: EXPERIMENTAL
Intervention: ALGOS (decision-making algorithm combining existing brief contact interventions)
Number of subjects: 1040
Study 30256552 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1040
Study 28480661 — intervention group
Group type: EXPERIMENTAL
Intervention: Avanafil 50 mg
Number of subjects: 158
Study 28480661 — intervention group
Group type: EXPERIMENTAL
Intervention: Avanafil 100 mg
Number of subjects: 158
Study 28480661 — intervention group
Group type: EXPERIMENTAL
Intervention: Avanafil 200 mg
Number of subjects: 158
Study 28480661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 26037035 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal (ID) bolus infusion of insulin aspart (NovoRapid U-100)
Number of subjects: 28
Study 26037035 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SC) bolus infusion of insulin aspart (NovoRapid U-100)
Number of subjects: 28
Study 23278132 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode Laser (DL)
Number of subjects: 30
Study 23278132 — intervention group
Group type: COMPARATOR
Intervention: Intense Pulsed Light (IPL)
Number of subjects: 30
Study 20920848 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily tobramycin and ceftazidime
Number of subjects: 146
Study 20920848 — intervention group
Group type: COMPARATOR
Intervention: Three-times daily tobramycin and ceftazidime
Number of subjects: 146
Study 19100416 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripterygium wilfordii (T II) 1 mg/kg/d for 12 months
Number of subjects: 36
Study 19100416 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 80 mg twice per day for 12 months
Number of subjects: 36
Study 16624683 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular reconstruction
Number of subjects: 74
Study 16624683 — intervention group
Group type: COMPARATOR
Intervention: Revascularization only
Number of subjects: 74
Study 14560327 — intervention group
Group type: EXPERIMENTAL
Intervention: SR restoration and maintenance
Number of subjects: 205
Study 14560327 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased left atrial area (<28 cm²)
Number of subjects: 205
Study 14560327 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in fractional shortening of the left ventricle (range 25-40%)
Number of subjects: 205
Study 11011878 — intervention group
Group type: EXPERIMENTAL
Intervention: Water exercise (70-min program: 10-min warm-up, 20-min brisk walking, 20-min rhythmic dancing, 10-min resistance training, 10-min cool down)
Number of subjects: 73
Study 11011878 — intervention group
Group type: COMPARATOR
Intervention: Land exercise (10-min warm-up, 30-min combined endurance and resistance exercise, 10-min cool down)
Number of subjects: 73
Study 8793604 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 30 mg i.v. (acute study)
Number of subjects: 24
Study 8793604 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once-daily oral doses (chronic study)
Number of subjects: 24
Study 8793604 — intervention group
Group type: COMPARATOR
Intervention: Control (no pantoprazole)
Number of subjects: 24
Study 1618253 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (4 micrograms.kg‐1.h‐1)
Number of subjects: 9
Study 1618253 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 9
Study 6432172 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg
Number of subjects: 44
Study 6432172 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 30 mg
Number of subjects: 44
Study 6432172 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg
Number of subjects: 44
Study 6432172 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 60 mg
Number of subjects: 44
Study 6432172 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 44
Study 31498121 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprenone (combined with donepezil)
Number of subjects: 79
Study 31498121 — intervention group
Group type: COMPARATOR
Intervention: Placebo (combined with donepezil)
Number of subjects: 79
Study 31498121 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprenone (combined with donepezil) in patients with mild atrophy
Number of subjects: 79
Study 31498121 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprenone (combined with donepezil) in patients with severe atrophy
Number of subjects: 79
Study 30304302 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Lavage (GL) with 10 ml of normal saline during vasectomy
Number of subjects: 60
Study 30304302 — intervention group
Group type: COMPARATOR
Intervention: Group Without Lavage (GWL) receiving only vasectomy
Number of subjects: 60
Study 26643851 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement in purposeful problem solving involving social science content
Number of subjects: 0
Study 26643851 — intervention group
Group type: COMPARATOR
Intervention: Observational learning (control group)
Number of subjects: 0
Study 24673052 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture method of tonifying‐qi and dredging‐meridian
Number of subjects: 70
Study 24673052 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture method
Number of subjects: 70
Study 23126260 — intervention group
Group type: EXPERIMENTAL
Intervention: True electroacupuncture
Number of subjects: 31
Study 23126260 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture (placebo)
Number of subjects: 31
Study 20105039 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard (ST) wave
Number of subjects: 18
Study 20105039 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (C) wave
Number of subjects: 18
Study 20105039 — intervention group
Group type: EXPERIMENTAL
Intervention: Square (SQ) wave
Number of subjects: 18
Study 20105039 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Combination (MC) wave
Number of subjects: 18
Study 17622884 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluconazole (400 mg loading dose followed by 200 mg QD for one week)
Number of subjects: 16
Study 17622884 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral fluconazole (400 mg loading dose followed by 200 mg QD for one week)
Number of subjects: 16
Study 15866999 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade sclerotherapy according to the Tauber procedure (group B)
Number of subjects: 64
Study 15866999 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (group A)
Number of subjects: 64
Study 11995262 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone (400 micrograms)
Number of subjects: 158
Study 11995262 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (5 or 10 mg according to age)
Number of subjects: 158
Study 11995262 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil (16 mg)
Number of subjects: 158
Study 11995262 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (24 micrograms)
Number of subjects: 158
Study 11995262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study 9558432 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane 0.2%
Number of subjects: 28
Study 9558432 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane 0.6%
Number of subjects: 28
Study 7604792 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg
Number of subjects: 48
Study 7604792 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 48
Study 7604792 — intervention group
Group type: COMPARATOR
Intervention: Tolbutamide
Number of subjects: 48
Study 7604792 — intervention group
Group type: COMPARATOR
Intervention: Glyburide
Number of subjects: 48
Study 7604792 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin or Simvastatin
Number of subjects: 48
Study 2196121 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin
Number of subjects: 63
Study 2196121 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (aminoglycoside, amoxicillin, clindamycin)
Number of subjects: 63
Study 372823 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly I:C immunotherapy
Number of subjects: 0
Study 29848599 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral TAP Group (Uni-TAP)
Number of subjects: 69
Study 29848599 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral TAP Group (Bi-TAP)
Number of subjects: 69
Study 29848599 — intervention group
Group type: COMPARATOR
Intervention: Local Anesthetic Infiltration (LAI) Group
Number of subjects: 69
Study 28673814 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-Regulated Volume-Controlled (PRVC) ventilation
Number of subjects: 70
Study 28673814 — intervention group
Group type: COMPARATOR
Intervention: Volume-Controlled ventilation
Number of subjects: 70
Study 26188923 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners (GP) managing iDDVT
Number of subjects: 167
Study 26188923 — intervention group
Group type: COMPARATOR
Intervention: Vascular medicine physicians (VMP) managing iDDVT
Number of subjects: 167
Study 26188923 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners (GP) monitoring anticoagulation
Number of subjects: 167
Study 26188923 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity of anticoagulation
Number of subjects: 167
Study 26188923 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of anticoagulation by GP
Number of subjects: 167
Study 26188923 — intervention group
Group type: COMPARATOR
Intervention: Duration of anticoagulation by VMP
Number of subjects: 167
Study 26188923 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of iDDVT as long as proximal DVT by GP
Number of subjects: 167
Study 26188923 — intervention group
Group type: COMPARATOR
Intervention: Treatment of iDDVT by VMP
Number of subjects: 167
Study 26188923 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic management comparison among GP
Number of subjects: 167
Study 23471512 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflated cuff
Number of subjects: 195
Study 23471512 — intervention group
Group type: COMPARATOR
Intervention: Inflated cuff
Number of subjects: 195
Study 21346689 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA)
Number of subjects: 120
Study 21346689 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure (control)
Number of subjects: 120
Study 18499009 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery before panretinal photocoagulation (surgery-first group)
Number of subjects: 29
Study 18499009 — intervention group
Group type: COMPARATOR
Intervention: Panretinal photocoagulation before cataract surgery (PRP-first group)
Number of subjects: 29
Study 16358612 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment protocol for heart failure patients in general practice, based on many RCT's and reviews.
Number of subjects: 0
Study 16358612 — intervention group
Group type: EXPERIMENTAL
Intervention: Co- and multi-medication in frail elderly patients.
Number of subjects: 0
Study 12079900 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid factors (RFs) measured by time resolved fluoroimmunoassay
Number of subjects: 155
Study 12079900 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease activity parameters (ESR, CRP, tender joint score, swollen joint score)
Number of subjects: 155
Study 12079900 — intervention group
Group type: EXPERIMENTAL
Intervention: Time integrated disease activity parameters
Number of subjects: 155
Study 9549821 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth curve model analysis
Number of subjects: 0
Study 9549821 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life data from a randomized trial
Number of subjects: 0
Study 8778008 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with prolapse of the genital organ
Number of subjects: 60
Study 8778008 — intervention group
Group type: COMPARATOR
Intervention: Women with normal statics
Number of subjects: 60
Study 2261821 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity (BMI >= 27 kg/m2 in men, >= 25 kg/m2 in women) and central obesity (waist-hip ratio >= 0.98 in men, >= 0.89 in women)
Number of subjects: 1300
Study 2261821 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of obesity and family history of diabetes
Number of subjects: 1300
Study 2261821 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous presence of obesity, central obesity, and family history of diabetes
Number of subjects: 1300
Study 2261821 — intervention group
Group type: EXPERIMENTAL
Intervention: Major risk factors for NIDDM (obesity, central fat distribution, family history of diabetes)
Number of subjects: 1300
Study 2261821 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence rates of NIDDM and IGT
Number of subjects: 1300
Study 2261821 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal glucose tolerance according to WHO criteria
Number of subjects: 1300
Study 753026 — intervention group
Group type: EXPERIMENTAL
Intervention: Estramustine and prednimustine combination
Number of subjects: 0
Study 753026 — intervention group
Group type: COMPARATOR
Intervention: Prednimustine alone
Number of subjects: 0
Study 753026 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover to estramustine after prednimustine therapy
Number of subjects: 0
Study 31365315 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for FGM among mothers
Number of subjects: 5048
Study 31365315 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of FGM's illegality among mothers
Number of subjects: 5048
Study 31365315 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for abandoning FGM among mullahs
Number of subjects: 5048
Study 31365315 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for abandoning FGM among mokhtars
Number of subjects: 5048
Study 31365315 — intervention group
Group type: EXPERIMENTAL
Intervention: Support for FGM by maternal education level
Number of subjects: 5048
Study 31365315 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of FGM among daughters
Number of subjects: 5048
Study 28488685 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated Fatty Acids (SFA) diet
Number of subjects: 26
Study 28488685 — intervention group
Group type: EXPERIMENTAL
Intervention: n-6 Polyunsaturated Fatty Acids (n-6PUFA) diet
Number of subjects: 26
Study 28488685 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain n-3 Polyunsaturated Fatty Acids (LCn-3PUFA) supplementation
Number of subjects: 26
Study 26252305 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin saline (HS) 50 U/mL
Number of subjects: 68
Study 26252305 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS) preservative-free 0.9% sodium chloride
Number of subjects: 68
Study 24158326 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulator (ES) technique with 0.2 ml/kg (E1)
Number of subjects: 58
Study 24158326 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulator (ES) technique with 0.6 ml/kg (E2)
Number of subjects: 58
Study 24158326 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulator (ES) technique with 1.0 ml/kg (E3)
Number of subjects: 58
Study 24158326 — intervention group
Group type: COMPARATOR
Intervention: Blinded technique with 1.0 ml/kg (B4)
Number of subjects: 58
Study 21266786 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary autologous freshly isolated bone marrow cells transplantation (BMCs‐Tx)
Number of subjects: 32
Study 21266786 — intervention group
Group type: COMPARATOR
Intervention: Control group without cell therapy
Number of subjects: 32
Study 19012356 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 3 mg/kg bid
Number of subjects: 0
Study 19012356 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 6 mg/kg bid
Number of subjects: 0
Study 19012356 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 7.5 mg/kg bid
Number of subjects: 0
Study 18432125 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonotherapy (ultrasound)
Number of subjects: 73
Study 18432125 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression therapy
Number of subjects: 73
Study 18432125 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 73
Study 14736768 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophilic hydrogel IOL
Number of subjects: 95
Study 14736768 — intervention group
Group type: COMPARATOR
Intervention: Hydrophobic acrylic IOL
Number of subjects: 95
Study 11554015 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous heparin infusion
Number of subjects: 0
Study 11554015 — intervention group
Group type: COMPARATOR
Intervention: Control group (no heparin infusion)
Number of subjects: 0
Study 9699231 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-model ANOVA
Number of subjects: 0
Study 9699231 — intervention group
Group type: EXPERIMENTAL
Intervention: Random coefficients model
Number of subjects: 0
Study 8148280 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 mg/kg/day CyA
Number of subjects: 251
Study 8148280 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg/day CyA
Number of subjects: 251
Study 8148280 — intervention group
Group type: EXPERIMENTAL
Intervention: CyA (both doses)
Number of subjects: 251
Study 3059891 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 5
Study 3059891 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Inspiratory Pressure (CPIP)
Number of subjects: 5
Study 3059891 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Expiratory Pressure (CPEP)
Number of subjects: 5
Study 30044938 — intervention group
Group type: EXPERIMENTAL
Intervention: BCX7353 125 mg
Number of subjects: 77
Study 30044938 — intervention group
Group type: EXPERIMENTAL
Intervention: BCX7353 250 mg
Number of subjects: 77
Study 30044938 — intervention group
Group type: EXPERIMENTAL
Intervention: BCX7353 350 mg
Number of subjects: 77
Study 30044938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 26565074 — intervention group
Group type: EXPERIMENTAL
Intervention: Home use of misoprostol
Number of subjects: 731
Study 26565074 — intervention group
Group type: COMPARATOR
Intervention: Clinic use of misoprostol
Number of subjects: 731
Study 25739969 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic RGB evaluation of tympanic membrane (TM) images in patients with OME
Number of subjects: 52
Study 25739969 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic RGB evaluation of tympanic membrane (TM) images in healthy controls
Number of subjects: 52
Study 25739969 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of viscosity of effusion in patients with OME
Number of subjects: 52
Study 23748750 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 400 mg qd
Number of subjects: 20